P5428Deterioration of vascular and hemodynamic markers during and after pegylated interferon and ribavirin treatment for chronic hepatitis C

Autor:	Larisa Vasilieva, I Mavroeidis, K Stamatelopoulos, A Mareti, L Karapanou, Ioannis Kanakakis, Iliana Mani, A Laina, D Bampatsias, Spyridon P. Dourakis, Evangelia Koutli, A Alexopoulou, Sophia Pouriki, Christos Papamichael, George Georgiopoulos
Rok vydání:	2018
Předmět:	medicine.medical_specialty business.industry Ribavirin Hemodynamics Gastroenterology chemistry.chemical_compound chemistry Chronic hepatitis Pegylated interferon Internal medicine medicine Cardiology and Cardiovascular Medicine business medicine.drug
Zdroj:	European Heart Journal. 39
ISSN:	1522-9645 0195-668X
DOI:	10.1093/eurheartj/ehy566.p5428
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::122f4152e58ff8eb8e6b2a65ce2be73b https://doi.org/10.1093/eurheartj/ehy566.p5428 Zobrazit plný text záznamu